Yizhak Eliav - El Al Chief Officer
| ELAL Stock | 846.50 12.20 1.46% |
Insider
Yizhak Eliav is Chief Officer of El Al Israel
| Age | 48 |
| Phone | 972 3 971 6720 |
| Web | https://www.elal.com |
El Al Management Efficiency
El Al's management efficiency ratios could be used to measure how well El Al manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Moni Feller | Delek Group | N/A | |
| Meni Baruch | Bezeq Israeli Telecommunication | 48 | |
| Eliav David | Bank Leumi Le Israel | N/A | |
| Naftali Sternlicht | Bezeq Israeli Telecommunication | N/A | |
| Amir Weiss | Teva Pharmaceutical Industries | 46 | |
| Raja Dakkuri | Bank Leumi Le Israel | 52 | |
| Avivit Klein | Bank Leumi Le Israel | 54 | |
| Janet Vergis | Teva Pharmaceutical Industries | 54 | |
| Kathleen Veit | Teva Pharmaceutical Industries | N/A | |
| David Paulson | Bank Leumi Le Israel | 60 | |
| Kare Schultz | Teva Pharmaceutical Industries | 62 | |
| David Fattal | Fattal 1998 Holdings | 66 | |
| Nadav Fattal | Fattal 1998 Holdings | 38 | |
| Shahar Aha | Fattal 1998 Holdings | 52 | |
| Yitzhak Oz | Delek Group | 58 | |
| Deborah Griffin | Teva Pharmaceutical Industries | N/A | |
| Zvika Abramovich | Bezeq Israeli Telecommunication | N/A | |
| Ronit SatchiFainaro | Teva Pharmaceutical Industries | 46 | |
| Lena Bernstein | Delek Group | 48 | |
| Shmulik Arbel | Bank Leumi Le Israel | 54 | |
| Eli Shani | Teva Pharmaceutical Industries | N/A | |
Management Performance
| Return On Equity | -14.84 | |||
| Return On Asset | -0.0035 |
El Al Israel Leadership Team
Elected by the shareholders, the El Al's board of directors comprises two types of representatives: El Al inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ELAL. The board's role is to monitor El Al's management team and ensure that shareholders' interests are well served. El Al's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, El Al's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Avigal Soreq, Pres CEO | ||
| Leehu Hacohen, VP Operations | ||
| Dafna Cohen, Director of Investor Relations | ||
| Oren Cohen, VP Service | ||
| Yizhak Eliav, Chief Officer | ||
| Moshe Cohen, Comptroller | ||
| Yehudit Grisaro, Vice President of Services |
ELAL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is El Al a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -14.84 | |||
| Return On Asset | -0.0035 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 6.9 B | |||
| Shares Outstanding | 190 M | |||
| Shares Owned By Insiders | 53.24 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Price To Book | 0.56 X | |||
| Price To Sales | 0.37 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in ELAL Stock
El Al financial ratios help investors to determine whether ELAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ELAL with respect to the benefits of owning El Al security.